Brief: Mankind Pharma and Astrazeneca Pharma India Enter Exclusive Distribution Agreement
11/03/2024 10:33
March 11 (Reuters) - Mankind Pharma Ltd MNKI.NS :
* ASTRAZENECA PHARMA INDIA, CO PARTNER TO ACCELERATE ACCESS TO ASTHMA
MEDICINE FOR
PATIENTS IN INDIA
* ENTERED AGREEMENT FOR EXCLUSIVE DISTRIBUTION OF ASTRAZENECA’S SYMBICORT
BRAND IN
INDIA
* ASTRAZENECA TO RETAIN INTELLECTUAL PROPERTY RIGHTS TO BUDESONIDE AND
FORMOTEROL
FUMARATE DIHYDRATE
* ASTRAZENECA TO CONTINUE TO BE MARKETING AUTHORISATION HOLDER AND IMPORT
LICENSE
Further company coverage: MNKI.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan